EUVIMEDEUVIMED entdecken
Open Access

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment

Rongjuan Wang, Chang Zhang, Yuting Cao, Junchao Wang, Shasha Jiao, Jiao Zhang, Min Wang, Peipei Tang, Zijun Ouyang, Wenlu Liang, Yu Mao, An Wang und 5 weitere

Theranostics · 2023

DOI: 10.7150/thno.79367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Rongjuan Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai 201210, China. Hauptthemen laut MEDLINE: Neoplasms, Antibodies, Bispecific. Die Arbeit wurde bisher 49-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntibodies, BispecificAnimalsMiceHumansImmune Checkpoint InhibitorsCD47 AntigenB7-H1 AntigenProgrammed Cell Death 1 ReceptorPhagocytosisImmunotherapy

Stichwörter der Autor:innen

Bispecific antibodyImmunity.ImmunotherapyPhagocytosisTherapeutic efficacy

Substanzen

Immune Checkpoint InhibitorsCD47 AntigenB7-H1 AntigenProgrammed Cell Death 1 ReceptorAntibodies, BispecificCD47 protein, human

Autor:innen und Institutionen

  • Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai 201210, China.
  • Beijing Kohnoor Science & Technology Co., Ltd., Beijing 102206, China.
  • School of Life Sciences, Anhui University, Hefei 230022, China.

Zitieren

APA

Wang, R., Zhang, C., Cao, Y., Wang, J., Jiao, S., Zhang, J., Wang, M., Tang, P., Ouyang, Z., Liang, W., Mao, Y., Wang, A., Li, G., Zhang, J., Wang, M., Wang, S., & Gui, X. (2023). Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment. Theranostics. https://doi.org/10.7150/thno.79367

Vancouver

Wang R, Zhang C, Cao Y, Wang J, Jiao S, Zhang J, et al. Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment. Theranostics. 2023. doi:10.7150/thno.79367

BibTeX
@article{Wang2023,
  author = {Wang, Rongjuan and Zhang, Chang and Cao, Yuting and Wang, Junchao and Jiao, Shasha and Zhang, Jiao and Wang, Min and Tang, Peipei and Ouyang, Zijun and Liang, Wenlu and Mao, Yu and Wang, An and Li, Gang and Zhang, Jinchao and Wang, Mingzhu and Wang, Shuang and Gui, Xun},
  title = {Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.79367}
}
Kostenlos starten →